[1]
Wilis Rakhmadhanti and Fef Rukminingsih 2022. EVALUASI BIAYA KEMOTERAPI PASIEN EARLY BREAST CANCER DI RSUD TUGUREJO SEMARANG PERIODE JULI-DESEMBER 2018. Journal Clinical Pharmacy and Pharmaceutical Science. 1, 1 (Apr. 2022), 01–08. DOI:https://doi.org/10.61740/jcp2s.v1i1.1.